Body Composition

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.

TL;DR

Excess adiposity is common in group 1 pulmonary hypertension, occurring in 4 out of 5 patients by waist/height ratio, and is associated with higher biventricular filling pressures, cardiac output demand, worse functional status, and reduced survival independent of insulin resistance.

Key Findings

Excess adiposity was highly prevalent in group 1 PH patients, with prevalence varying substantially by measurement method.

  • Among 418 group 1 PH patients, 158 (38%) had BMI ≥30 kg/m²
  • Among those with waist circumference measurement (n=375), 287 (77%) had excess adiposity by elevated waist/height ratio
  • 214 (57%) had elevated waist circumference
  • Excess adiposity was present in 4 out of 5 patients by waist/height ratio, compared to only 2 out of 5 by traditional BMI criteria

Insulin resistance co-occurred frequently with obesity but was also present in a substantial minority of non-obese group 1 PH patients.

  • Among the 158 patients with BMI ≥30 kg/m², 94 (60%) had IR (HOMA-IR ≥2.6)
  • Among the 260 patients with BMI <30 kg/m², 74 (28%) had IR
  • IR was defined using a HOMA-IR threshold of ≥2.6

Patients with obesity had worse quality of life, exercise capacity, and left heart remodeling compared to non-obese group 1 PH patients.

  • Differences in quality of life, exercise capacity, and left heart remodeling were statistically significant (P<0.0001 for all)
  • Obese patients had higher resting and dynamic pulmonary capillary wedge pressure (PCWP), right atrial pressure, and cardiac output (P<0.0001 for all)

Higher PCWP response with obesity persisted after adjusting for insulin resistance, whereas IR itself was not independently associated with PCWP response.

  • IR-adjusted PCWP was +2.5 mm Hg (95% CI, +1.4 to +3.6; P<0.0001) higher in obese versus non-obese patients
  • All adiposity indices were consistently associated with PCWP response, but IR was not
  • Dynamic PCWP responses were compared using repeated-measure mixed models

Greater visceral adiposity was independently associated with worse survival in group 1 PH patients.

  • Body shape index was associated with worse survival (hazard ratio, 2.01 [95% CI, 1.16–3.47]; P=0.01)
  • Weight-adjusted waist index was also associated with worse survival (hazard ratio, 1.64 [95% CI, 1.10–2.46]; P=0.01)
  • Both body shape index and weight-adjusted waist index are measures of visceral adiposity

Adiposity indices were consistently associated with higher right atrial pressure and cardiac output in addition to PCWP.

  • Similar associations were observed between adiposity indices and higher right atrial pressure and cardiac output
  • These associations were assessed using repeated-measure mixed models for dynamic hemodynamic responses
  • The associations with right atrial pressure and cardiac output were also statistically significant (P<0.0001)

The study was conducted within the PVDOMICS cohort, which measured multiple adiposity and metabolic indices in group 1 PH patients.

  • PVDOMICS stands for Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics
  • Measures included HOMA-IR, BMI, fat mass, and waist circumference
  • Dynamic pulmonary capillary wedge pressure and right atrial pressure responses were compared stratified by obesity (BMI ≥30 kg/m²) and IR status (HOMA-IR ≥2.6)
  • Total group 1 PH sample size was 418 patients; waist circumference was available in 375

The authors concluded that their data support trials of adipose-reducing therapies in patients with group 1 PH and excess adiposity.

  • Excess adiposity was associated with higher biventricular filling pressures, cardiac output demand, worse functional status, and reduced survival
  • The effect of adiposity on hemodynamics was independent of insulin resistance
  • Authors explicitly called for 'trials of adipose-reducing therapies in patients with group 1 PH and excess adiposity'

Have a question about this study?

Citation

Reddy Y, Frantz R, Hemnes A, Hassoun P, Horn E, Leopold J, et al.. (2026). Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.. Circulation. Heart failure. https://doi.org/10.1161/CIRCHEARTFAILURE.125.013591